Open-Label Placebo for Functional Dyspepsia

• Status: Terminated
• Trial end date: 2019-10-07
• Target enrollment: 0
• Participant gender: All

Summary

The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center

Criteria

Inclusion Criteria:

• Functional Dyspepsia

Exclusion Criteria:

-